Fierce Biotech May 25, 2023
Though the smallest of Medtronic’s four core businesses, the diabetes department has taken center stage as of late.
Fresh off reaching a resolution with the FDA over a warning letter concerning its diabetes business headquarters in California—which in turn came just as the agency finally handed down the long-awaited clearance of Medtronic’s latest MiniMed insulin pump—the company has inked a deal to further expand the portfolio.
Medtronic is set to acquire EOFlow, the South Korea-based maker of an insulin patch pump. In its announcement of the deal Thursday, Medtronic suggested that integrating the tubeless device with its own continuous glucose monitors and meal-detection algorithm—both of which can also be used alongside the MiniMed pumps—could create a new closed-loop...
Today's Sponsors
Today's Sponsor